| Product Code: ETC8616067 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of valganciclovir to Niger in 2024 were sourced primarily from India, France, Egypt, China, and Denmark. The market concentration, as measured by the HHI, shifted from low to moderate in 2024, indicating a more balanced distribution among suppliers. Despite a negative compound annual growth rate (CAGR) of -2.05% from 2020 to 2024, the industry experienced a notable growth rate of 17.78% from 2023 to 2024. This suggests a recent uptick in demand for valganciclovir in Niger, potentially driven by various factors such as healthcare developments or changing market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Valganciclovir Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Valganciclovir Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Valganciclovir Market - Industry Life Cycle |
3.4 Niger Valganciclovir Market - Porter's Five Forces |
3.5 Niger Valganciclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Valganciclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Niger Valganciclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cytomegalovirus (CMV) infections in Niger |
4.2.2 Growing awareness about the benefits of valganciclovir in treating CMV infections |
4.2.3 Rising healthcare expenditure and infrastructure development in Niger |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Niger |
4.3.2 High cost of valganciclovir treatment |
4.3.3 Lack of skilled healthcare professionals in managing CMV infections |
5 Niger Valganciclovir Market Trends |
6 Niger Valganciclovir Market, By Types |
6.1 Niger Valganciclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Valganciclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Niger Valganciclovir Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 Niger Valganciclovir Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2 Niger Valganciclovir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Niger Valganciclovir Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 Niger Valganciclovir Market Revenues & Volume, By Children, 2021- 2031F |
7 Niger Valganciclovir Market Import-Export Trade Statistics |
7.1 Niger Valganciclovir Market Export to Major Countries |
7.2 Niger Valganciclovir Market Imports from Major Countries |
8 Niger Valganciclovir Market Key Performance Indicators |
8.1 Number of CMV cases diagnosed annually in Niger |
8.2 Adoption rate of valganciclovir as a preferred treatment for CMV infections |
8.3 Number of healthcare facilities offering valganciclovir treatment in Niger |
9 Niger Valganciclovir Market - Opportunity Assessment |
9.1 Niger Valganciclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Valganciclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Niger Valganciclovir Market - Competitive Landscape |
10.1 Niger Valganciclovir Market Revenue Share, By Companies, 2024 |
10.2 Niger Valganciclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |